| For: | Zhu YX, Zhang W, Qu HL, Zhang Y, Zhou RQ, Li P, Wang F, Zhang Y, Liu HH, Li S, Dong Q, Dou KF, Guo YL, Li JJ, Xu RX. Liraglutide alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by enhancing mitophagy mediated by the AMPK-Parkin signaling pathway. World J Diabetes 2025; 16(12): 112423 [PMID: 41480600 DOI: 10.4239/wjd.v16.i12.112423] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i12/112423.htm |
| Number | Citing Articles |
| 1 |
Guangzhen Lu, Xinye Wang, Hong Zhuang, Xiaoting Wang, Xin Zhou, Gang Zhao. Tirzepatide attenuates cardiac microvascular injury and ferroptosis-related lipid peroxidation in diabetic mice: endothelial responses in the context of partial PRKN silencing. European Journal of Pharmacology 2026; 1036 doi: 10.1016/j.ejphar.2026.179387
|
| 2 |
Ke Su, Pei-Yan Cao, Gan Chen, Ke Wu. Letter to the Editor: Is the cellular attribution of liraglutide action in diabetic cardiomyopathy conclusive?. World Journal of Diabetes 2026; 17(7): 117243 doi: 10.4239/wjd.117243
|
| 3 |
Tao Tang, Jing Zhou, Xianbo Jia, Jiahao Shao, Meigui Wang, Siqi Xia, Shuai Chen, Wenqiang Sun, Jie Wang, Songjia Lai. β-Hydroxybutyrate-induced mitochondrial dysfunction and oxidative stress in BMSCs are ameliorated by mitophagy activation. Frontiers in Cell and Developmental Biology 2026; 14 doi: 10.3389/fcell.2026.1926968
|